Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
14 Fevereiro 2025 - 12:16PM
Edgar (US Regulatory)
Exhibit A
JOINT FILING AGREEMENT
The undersigned agree that
this Schedule 13G Amendment No. 2 dated February 14, 2025 relating to the Common Stock, par value $0.0001, of Immunic, Inc. shall be filed
on behalf of the undersigned.
| |
AVIDITY PARTNERS MANAGEMENT LP
By Avidity Partners Management (GP) LLC, its general partner
By: /s/ Michael Gregory |
| |
Title: Managing Member |
| |
AVIDITY PARTNERS MANAGEMENT (GP) LLC
By: /s/ Michael Gregory |
| |
Title: Managing Member |
| |
AVIDITY CAPITAL PARTNERS FUND (GP) LP
By Avidity Capital Partners (GP) LLC, its general partner
By: /s/ Michael Gregory |
| |
Title: Managing Member |
| |
AVIDITY CAPITAL PARTNERS (GP) LLC
By: /s/ Michael Gregory |
| |
Title: Managing Member |
| |
AVIDITY PRIVATE MASTER FUND I LP
By Avidity Capital Partners Fund (GP) LP, its general partner
By: Avidity
Capital Partners (GP) LLC, its general partner
By: /s/ Michael Gregory |
| |
Title: Managing Member |
| |
DAVID WITZKE
By: /s/ David Witzke |
| |
MICHAEL GREGORY
By: /s/ Michael Gregory |
Immunic (NASDAQ:IMUX)
Gráfico Histórico do Ativo
De Fev 2025 até Mar 2025
Immunic (NASDAQ:IMUX)
Gráfico Histórico do Ativo
De Mar 2024 até Mar 2025
